AI assistant
Amphastar Pharmaceuticals, Inc. — Director's Dealing 2015
Jun 10, 2015
10216_dirs_2015-06-09_8b8c482c-8e66-480d-bf8e-b989d566fa1c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Amphastar Pharmaceuticals, Inc. (AMPH)
CIK: 0001297184
Period of Report: 2015-03-27
Reporting Person: Zhang Jack Y. (Director, CEO & Chief Science Officer, 10% Owner)
Reporting Person: Luo Mary Z. (Director, COO, Chief Scientist, Chairman, 10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-27 | Common Stock | F | 20877 | $15.43 | Disposed | 911636 | Direct |
| 2015-06-05 | Common Stock | M | 48980 | $12.97 | Acquired | 960616 | Direct |
| 2015-06-05 | Common Stock | S | 44149 | $16.4642 | Disposed | 916467 | Direct |
| 2015-06-08 | Common Stock | M | 30066 | $12.97 | Acquired | 946533 | Direct |
| 2015-06-08 | Common Stock | S | 27020 | $16.614 | Disposed | 919513 | Direct |
| 2015-06-09 | Common Stock | M | 28324 | $12.97 | Acquired | 947837 | Direct |
| 2015-06-09 | Common Stock | S | 25700 | $16.2356 | Disposed | 922137 | Direct |
| 2015-03-27 | Common Stock | F | 8641 | $15.43 | Disposed | 661666 | Indirect |
| 2015-06-05 | Common Stock | M | 50162 | $12.97 | Acquired | 711828 | Indirect |
| 2015-06-05 | Common Stock | S | 43989 | $16.4657 | Disposed | 667839 | Indirect |
| 2015-06-08 | Common Stock | M | 30152 | $12.97 | Acquired | 697991 | Indirect |
| 2015-06-08 | Common Stock | S | 27100 | $16.6087 | Disposed | 670891 | Indirect |
| 2015-06-09 | Common Stock | M | 28433 | $12.97 | Acquired | 699324 | Indirect |
| 2015-06-09 | Common Stock | S | 25800 | $16.1229 | Disposed | 673524 | Indirect |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-06-05 | Employee Stock Option (right to buy) | $12.97 | M | 48980 | Disposed | 2015-09-28 | Common Stock (48980) | Direct |
| 2015-06-08 | Employee Stock Option (right to buy) | $12.97 | M | 30066 | Disposed | 2015-09-28 | Common Stock (30066) | Direct |
| 2015-06-09 | Employee Stock Option (right to buy) | $12.97 | M | 28324 | Disposed | 2015-09-28 | Common Stock (28324) | Direct |
| 2015-06-05 | Employee Stock Option (right to buy) | $12.97 | M | 50162 | Disposed | 2015-09-28 | Common Stock (50162) | Indirect |
| 2015-06-08 | Employee Stock Option (right to buy) | $12.97 | M | 30152 | Disposed | 2015-09-28 | Common Stock (30152) | Indirect |
| 2015-06-09 | Employee Stock Option (right to buy) | $12.97 | M | 28433 | Disposed | 2015-09-28 | Common Stock (28433) | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 7631594 | Indirect |
| Common Stock | 5000 | Indirect |
| Common Stock | 200000 | Indirect |
Footnotes
F1: The reported securities were withheld to satisfy the Reporting Person's tax liability in connection with the vesting of deferred stock units (DSUs).
F2: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the each of the reporting persons on December 16, 2014.
F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.28 to $16.5015, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4), (5), (7), (8) and (9) to this Form 4.
F4: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.41 to $16.85, inclusive.
F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.50 to $16.595, inclusive.
F6: The securities are held of record by Mary Z. Luo. The reporting persons are husband and wife.
F7: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.28 to $16.52, inclusive.
F8: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.41 to $16.825, inclusive.
F9: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.595, inclusive.
F10: The shares are held of record by Applied Physics & Chemistry Laboratories, Inc., of which the reporting persons are the sole owners.
F11: The shares are held of record in an account for the benefit of the reporting persons' son. The reporting persons disclaims beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
F12: The shares are held of record by a trust for the benefit of the reporting persons' son. The reporting persons disclaims beneficial ownership of these shares, and the inclusion of these shares in this report should not be deemed an admission of beneficial ownership of any such shares for purposes of Section 16, or for any other purpose.
F13: Shares subject to the option are fully vested and immediately exercisable.